What it’s used for:
Primarily studied for reducing visceral fat in HIV-associated lipodystrophy, and for general applications in body composition and anti-aging.
Benefits:
Possible Side Effects:
FDA Status:
FDA approved in 2010 for reducing abdominal fat in HIV patients with lipodystrophy.
FDA Registration: NDC 44087-1100
Disclaimer:
IMPORTANT NOTICE: The buyer is responsible for their own research. Vanguard BioLabs does not provide dosage guidelines or application instructions. This product is sold for research purposes only.
Disclaimer – Research Use Only
All information provided is strictly for research purposes. The peptides offered are intended solely for scientific study by qualified professionals. They are not for human use, medical, veterinary, or household purposes. This content does not constitute medical or legal advice, nor does it endorse any non-research application. Products must be reconstituted with bacteriostatic water and handled responsibly. Use is governed by our Terms & Conditions.